Active immunization of metastatic melanoma patients with IL-2 or IL-4 gene transfected, allogeneic melanoma cells

Adv Exp Med Biol. 1998:451:543-5. doi: 10.1007/978-1-4615-5357-1_84.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Genetic Therapy* / adverse effects
  • Humans
  • Immunization Schedule
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / genetics*
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / genetics*
  • Melanoma / immunology*
  • Melanoma / therapy*
  • Neoplasm Staging
  • Recombinant Proteins / biosynthesis
  • Transfection
  • Transplantation, Homologous
  • Tumor Cells, Cultured / transplantation*
  • Vaccination* / adverse effects

Substances

  • Interleukin-2
  • Recombinant Proteins
  • Interleukin-4